Immunotherapy in breast cancer: current practice and clinical challenges

D de Melo Gagliato, AC Buzaid, J Perez-Garcia… - BioDrugs, 2020 - Springer
Immunotherapy is currently approved for a subset of patients diagnosed with advanced triple
negative breast cancer (TNBC), based on the phase III randomized controlled trial …
被引用次数：52 相关文章

Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges

D de Melo Gagliato, AC Buzaid, J Perez-Garcia… - …, 2020 - search.proquest.com
Immunotherapy is currently approved for a subset of patients diagnosed with advanced triple
negative breast cancer (TNBC), based on the phase III randomized controlled trial …

Immunotherapy in Breast Cancer: Current Practice and Clinical Challenges

D de Melo Gagliato, AC Buzaid… - … and gene therapy, 2020 - pubmed.ncbi.nlm.nih.gov
Immunotherapy is currently approved for a subset of patients diagnosed with advanced triple
negative breast cancer (TNBC), based on the phase III randomized controlled trial …